Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study: clinical research : clinical trials

To report 5-year outcomes of EFFORTLESS registry patients with early generation subcutaneous implantable cardioverter-defibrillator (S-ICD) devices.Kaplan-Meier, trend and multivariable analyses were performed for mortality and late (years 2-5) complications, appropriate shock (AS) and inappropriate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Lambiase, Pier D. (VerfasserIn) , Theuns, Dominic A (VerfasserIn) , Murgatroyd, Francis (VerfasserIn) , Barr, Craig (VerfasserIn) , Eckardt, Lars (VerfasserIn) , Neuzil, Petr (VerfasserIn) , Scholten, Marcoen (VerfasserIn) , Hood, Margaret (VerfasserIn) , Kuschyk, Jürgen (VerfasserIn) , Brisben, Amy J (VerfasserIn) , Carter, Nathan (VerfasserIn) , Stivland, Timothy M (VerfasserIn) , Knops, Reinoud (VerfasserIn) , Boersma, Lucas V A (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 1 June 2022
In: European heart journal
Year: 2022, Jahrgang: 43, Heft: 21, Pages: 2037-2050
ISSN:1522-9645
DOI:10.1093/eurheartj/ehab921
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehab921
Verlag, lizenzpflichtig, Volltext: https://academic.oup.com/eurheartj/article/43/21/2037/6516831?login=true
Volltext
Verfasserangaben:Pier D. Lambiase, Dominic A. Theuns, Francis Murgatroyd, Craig Barr, Lars Eckardt, Petr Neuzil, Marcoen Scholten, Margaret Hood, Jȕrgen Kuschyk, Amy J. Brisben, Nathan Carter, Timothy M. Stivland, Reinoud Knops, Lucas V.A. Boersma, and on behalf of the EFFORTLESS Investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1878695495
003 DE-627
005 20240307080250.0
007 cr uuu---uuuuu
008 240123s2022 xx |||||o 00| ||eng c
024 7 |a 10.1093/eurheartj/ehab921  |2 doi 
035 |a (DE-627)1878695495 
035 |a (DE-599)KXP1878695495 
035 |a (OCoLC)1425215403 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Lambiase, Pier D.  |e VerfasserIn  |0 (DE-588)1316952797  |0 (DE-627)1878696300  |4 aut 
245 1 0 |a Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study  |b clinical research : clinical trials  |c Pier D. Lambiase, Dominic A. Theuns, Francis Murgatroyd, Craig Barr, Lars Eckardt, Petr Neuzil, Marcoen Scholten, Margaret Hood, Jȕrgen Kuschyk, Amy J. Brisben, Nathan Carter, Timothy M. Stivland, Reinoud Knops, Lucas V.A. Boersma, and on behalf of the EFFORTLESS Investigators 
264 1 |c 1 June 2022 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 28 January 2022 
500 |a Gesehen am 23.01.2024 
520 |a To report 5-year outcomes of EFFORTLESS registry patients with early generation subcutaneous implantable cardioverter-defibrillator (S-ICD) devices.Kaplan-Meier, trend and multivariable analyses were performed for mortality and late (years 2-5) complications, appropriate shock (AS) and inappropriate shock (IAS) rates. Nine hundred and eighty-four of 994 enrolled patients with diverse diagnoses (28% female, 48 ± 17 years, body mass index 27 ± 6 kg/m2, ejection fraction 43 ± 18%) underwent S-ICD implantation. Median follow-up was 5.1 years (interquartile range 4.7-5.5 years). All-cause mortality was 9.3% (95% confidence interval 7.2-11.3%) at 5 years; 703 patients remained in follow-up on study completion, 171 withdrew including 87 (8.8%) with device explanted, and 65 (6.6%) lost to follow-up. Of the explants, only 20 (2.0%) patients needed a transvenous device for pacing indications. First and final shock efficacy for discrete ventricular arrhythmias was consistent at 90% and 98%, respectively, with storm episode final shock efficacy at 95.2%. Time to therapy remained unaltered. Overall 1- and 5-year complication rates were 8.9% and 15.2%, respectively. Early complications did not predict later complications. There were no structural lead failures. Inappropriate shock rates at 1 and 5 years were 8.7% and 16.9%, respectively. Self-terminating inappropriately sensed episodes predicted late IAS. Predictors of late AS included self-terminating appropriately sensed episodes and earlier AS.In this diverse S-ICD registry population, spontaneous shock efficacy was consistently high over 5 years. Very few patients underwent S-ICD replacement with a transvenous device for pacing indications. Treated and self-terminating arrhythmic episodes predict future shock events, which should encourage more personalized device optimization. 
700 1 |a Theuns, Dominic A  |e VerfasserIn  |4 aut 
700 1 |a Murgatroyd, Francis  |e VerfasserIn  |4 aut 
700 1 |a Barr, Craig  |e VerfasserIn  |4 aut 
700 1 |a Eckardt, Lars  |e VerfasserIn  |4 aut 
700 1 |a Neuzil, Petr  |e VerfasserIn  |4 aut 
700 1 |a Scholten, Marcoen  |e VerfasserIn  |4 aut 
700 1 |a Hood, Margaret  |e VerfasserIn  |4 aut 
700 1 |a Kuschyk, Jürgen  |d 1968-  |e VerfasserIn  |0 (DE-588)122441850  |0 (DE-627)081944993  |0 (DE-576)293272212  |4 aut 
700 1 |a Brisben, Amy J  |e VerfasserIn  |4 aut 
700 1 |a Carter, Nathan  |e VerfasserIn  |4 aut 
700 1 |a Stivland, Timothy M  |e VerfasserIn  |4 aut 
700 1 |a Knops, Reinoud  |e VerfasserIn  |4 aut 
700 1 |a Boersma, Lucas V A  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European heart journal  |d Oxford : Oxford University Press, 1980  |g 43(2022), 21 vom: Juni, Seite 2037-2050  |h Online-Ressource  |w (DE-627)320415813  |w (DE-600)2001908-7  |w (DE-576)103746846  |x 1522-9645  |7 nnas  |a Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study clinical research : clinical trials 
773 1 8 |g volume:43  |g year:2022  |g number:21  |g month:06  |g pages:2037-2050  |g extent:14  |a Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study clinical research : clinical trials 
856 4 0 |u https://doi.org/10.1093/eurheartj/ehab921  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://academic.oup.com/eurheartj/article/43/21/2037/6516831?login=true  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240123 
993 |a Article 
994 |a 2022 
998 |g 122441850  |a Kuschyk, Jürgen  |m 122441850:Kuschyk, Jürgen  |d 60000  |e 60000PK122441850  |k 0/60000/  |p 9 
999 |a KXP-PPN1878695495  |e 4466328706 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1878695495","note":["Online veröffentlicht: 28 January 2022","Gesehen am 23.01.2024"],"name":{"displayForm":["Pier D. Lambiase, Dominic A. Theuns, Francis Murgatroyd, Craig Barr, Lars Eckardt, Petr Neuzil, Marcoen Scholten, Margaret Hood, Jȕrgen Kuschyk, Amy J. Brisben, Nathan Carter, Timothy M. Stivland, Reinoud Knops, Lucas V.A. Boersma, and on behalf of the EFFORTLESS Investigators"]},"relHost":[{"pubHistory":["1.1980 -"],"recId":"320415813","note":["Gesehen am 12.09.2017"],"disp":"Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study clinical research : clinical trialsEuropean heart journal","part":{"volume":"43","pages":"2037-2050","text":"43(2022), 21 vom: Juni, Seite 2037-2050","year":"2022","extent":"14","issue":"21"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"European heart journal","title_sort":"European heart journal"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1522-9645"],"zdb":["2001908-7"],"eki":["320415813"]},"language":["eng"],"origin":[{"dateIssuedKey":"1980","publisher":"Oxford University Press ; Harcourt","publisherPlace":"Oxford ; London [u.a.]","dateIssuedDisp":"1980-"}]}],"title":[{"title_sort":"Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study","title":"Subcutaneous implantable cardioverter-defibrillators: long-term results of the EFFORTLESS study","subtitle":"clinical research : clinical trials"}],"person":[{"given":"Pier D.","family":"Lambiase","display":"Lambiase, Pier D.","role":"aut"},{"display":"Theuns, Dominic A","family":"Theuns","given":"Dominic A","role":"aut"},{"role":"aut","family":"Murgatroyd","display":"Murgatroyd, Francis","given":"Francis"},{"family":"Barr","display":"Barr, Craig","given":"Craig","role":"aut"},{"given":"Lars","display":"Eckardt, Lars","family":"Eckardt","role":"aut"},{"role":"aut","given":"Petr","display":"Neuzil, Petr","family":"Neuzil"},{"role":"aut","display":"Scholten, Marcoen","family":"Scholten","given":"Marcoen"},{"role":"aut","family":"Hood","display":"Hood, Margaret","given":"Margaret"},{"family":"Kuschyk","display":"Kuschyk, Jürgen","given":"Jürgen","role":"aut"},{"role":"aut","given":"Amy J","display":"Brisben, Amy J","family":"Brisben"},{"role":"aut","given":"Nathan","display":"Carter, Nathan","family":"Carter"},{"role":"aut","display":"Stivland, Timothy M","family":"Stivland","given":"Timothy M"},{"role":"aut","display":"Knops, Reinoud","family":"Knops","given":"Reinoud"},{"role":"aut","display":"Boersma, Lucas V A","family":"Boersma","given":"Lucas V A"}],"physDesc":[{"extent":"14 S."}],"origin":[{"dateIssuedDisp":"1 June 2022","dateIssuedKey":"2022"}],"id":{"eki":["1878695495"],"doi":["10.1093/eurheartj/ehab921"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"]} 
SRT |a LAMBIASEPISUBCUTANEO1202